Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
Rennova Health had revenue of $19.59M in the twelve months ending June 30, 2023, with 154.54% growth year-over-year. Revenue in the quarter ending June 30, 2023 was $6.39M with 77.17% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth